Ian Mortimer
Chief Executive Officer bij XENON PHARMACEUTICALS INC.
Vermogen: 2 M $ op 29-02-2024
Profiel
Currently, Ian C.
Mortimer holds the position of President, Chief Executive Officer & Director at Xenon Pharmaceuticals, Inc. and President, Treasurer & Director at Xenon Pharmaceuticals USA, Inc. (a subsidiary of Xenon Pharmaceuticals, Inc.).
Mr. Mortimer is also on the board of Perimeter Medical Imaging, Inc. and Perimeter Medical Imaging AI, Inc.
He previously was Chairman for Appili Therapeutics, Inc. and Chief Financial Officer & Executive Vice President of Arbutus Biopharma Corp.
Mr. Mortimer received an undergraduate degree from the University of British Columbia and an MBA from Queen's University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
11-03-2024 | 45 602 ( 0.06% ) | 2 M $ | 29-02-2024 | |
08-11-2023 | 113 333 ( 0.17% ) | 81 373 $ | 29-02-2024 |
Actieve functies van Ian Mortimer
Bedrijven | Functie | Begin |
---|---|---|
XENON PHARMACEUTICALS INC. | Chief Executive Officer | 03-06-2021 |
PERIMETER MEDICAL IMAGING AI, INC. | Director/Board Member | 03-07-2020 |
Xenon Pharmaceuticals USA, Inc.
Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA. | President | - |
Perimeter Medical Imaging, Inc.
Perimeter Medical Imaging, Inc. Medical SpecialtiesHealth Technology Perimeter Medical Imaging, Inc. provides medical services. It develops, patents and commercializes surgical imaging tools that allow surgeons, radiologists, and pathologists to assess microscopic tissue structures during surgical procedures. It offers OTIS Optical Tissue Imaging Console, OTIS Tissue Immobilization System, OTIS Proprietary Imaging Atlas, and Next Generation OTIS AI Tissue Assessment Algorithms. The company was founded by Elizabeth Munro, David Rempel, Andrew Berkeley, Arsen R. Hajian, and Gordon Cheung in 2013 and is headquartered in Toronto, Canada. | Director/Board Member | 03-07-2020 |
Eerdere bekende functies van Ian Mortimer
Bedrijven | Functie | Einde |
---|---|---|
ARBUTUS BIOPHARMA CORPORATION | Director of Finance/CFO | 01-10-2013 |
APPILI THERAPEUTICS INC. | Chairman | - |
Opleiding van Ian Mortimer
Queen's University | Masters Business Admin |
University of British Columbia | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
ARBUTUS BIOPHARMA CORPORATION | Health Technology |
XENON PHARMACEUTICALS INC. | Health Technology |
APPILI THERAPEUTICS INC. | Health Technology |
PERIMETER MEDICAL IMAGING AI, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Perimeter Medical Imaging, Inc.
Perimeter Medical Imaging, Inc. Medical SpecialtiesHealth Technology Perimeter Medical Imaging, Inc. provides medical services. It develops, patents and commercializes surgical imaging tools that allow surgeons, radiologists, and pathologists to assess microscopic tissue structures during surgical procedures. It offers OTIS Optical Tissue Imaging Console, OTIS Tissue Immobilization System, OTIS Proprietary Imaging Atlas, and Next Generation OTIS AI Tissue Assessment Algorithms. The company was founded by Elizabeth Munro, David Rempel, Andrew Berkeley, Arsen R. Hajian, and Gordon Cheung in 2013 and is headquartered in Toronto, Canada. | Health Technology |
Xenon Pharmaceuticals USA, Inc.
Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA. | Health Technology |